Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: UMLS:C0033036 (
APC
)
10,214
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
A case of deep-vein thrombosis in a 23-year old woman 1 month after starting oral contraceptives is described, the 1st known incident of defective Protein S activity with normal levels of Protein S but defective
APC
cofactor. The woman had no known personal risk factors or family history of thromboembolism. She noticed pain and swelling of her right leg, and on admission to the Institute of Internal Medicine of the University of Milan, bilateral leg venography demonstrated occlusion of the right popliteal, femoral and iliac veins. She was treated with intravenous heparin for 10 days, and then warfarin. Protein S is a vitamin K-dependent plasma protein which binds to platelets and endothelial cells and functions as a cofactor for Protein C in the proteolytic cleavage of the activated forms of coagulation factors V and VIII. Persons with Protein S deficiency are at a high risk for thromboembolism. All coagulation laboratory screens were normal on repeated testing of the proband's plasma before initiating therapy, as well as her family members. In this patient total protein S antigen was low normal by
EIA
and ELISA.
APC
-cofactor was the only assay clearly abnormal, in the proband, her mother, siblings and maternal uncle;
APC
- cofactor activity was restored to normal by adding back pure Protein S.
...
PMID:Familial dysfunction of protein S. 253 Jun 48
Objective. To compare longitudinally
PAC
of asthmatic children against that of healthy controls during ten months. Methods. Twenty-eight asthmatic children aged 7-15 years and 27 matched controls each performed six submaximal exercise tests on treadmill, which included a test of
EIA
(exercise-induced asthma). Predicted aerobic capacity (mLO(2)/min/kg) was calculated. Spirometry and development were measured. Physical activity, medication, and "ever asthma/current asthma" were reported by questionnaire. Results. Predicted aerobic capacity of asthmatics was lower than that of controls (P = 0.0015) across observation times and for both groups an important increase in predicted aerobic capacity according to time was observed (P < 0.001). FEV(1) of the asthmatic children was within normal range. The majority (86%) of the asthmatics reported pulmonary symptoms to accompany their physical activity. Physical activity (hours per week) showed important effects for the variation in predicted aerobic capacity at baseline (F = 2.28, P = 0.061) and at the T4 observation (F = 3.03, P = 0.027) and the analyses showed important asthma/control group effects at baseline, month four, and month ten. Physical activity of the asthmatics correlated positively with predicted aerobic capacity. Conclusion. The asthmatic children had consistently low
PAC
when observed across time. Physical activity was positively associated with
PAC
in the asthmatics.
...
PMID:Predicted aerobic capacity of asthmatic children: a research study from clinical origin. 2290 Jan 71